STAT in DC: Policy in Health Care
Join STAT’s leading DC bureau as they take the stage with policymakers, patient advocates, and industry experts to discuss the biggest issues in health policy and the decisions shaping the future of health care.
Join STAT’s leading DC bureau as they take the stage with policymakers, patient advocates, and industry experts to discuss the biggest issues in health policy and the decisions shaping the future of health care.
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies:…
Eli Lilly raised its full-year guidance while it reported strong first-quarter sales of Zepbound, its obesity drug.
Advocates of a federal ban on menthol cigarettes have spent years trying everything to sway policymakers — now, it seems, they may just have to…
In a challenge to the pharmaceutical industry, Doctors Without Borders has revealed the detailed costs of a study it ran for a tuberculosis treatment regimen.
Good health has little to do with what happens in a doctor’s office. Paying for nutritious food and the like should be seen as preventive…
Excluding pregnant people from research fails to prevent harm to them and their offspring — and actually increases it.
Questions about H5N1 for which there are pretty clear answers when it comes to birds are suddenly unsettled science in cows.
A New Jersey district judge ruled that the Biden administration’s Medicare drug price negotiation program is constitutional
Practice Network, a new initiative, aims to help smaller hospitals implement AI tools in local settings where adoption is currently stymied.
The agency released its final plan on Monday. Overall, the FDA estimates that around 12,000 labs will have to start submitting their tests.